The post Will It Break Higher or Pull Back? appeared on BitcoinEthereumNews.com. LayerZero is hovering at $1.79. ZRO trading volume dropped by 28%. As of March The post Will It Break Higher or Pull Back? appeared on BitcoinEthereumNews.com. LayerZero is hovering at $1.79. ZRO trading volume dropped by 28%. As of March

Will It Break Higher or Pull Back?

For feedback or concerns regarding this content, please contact us at [email protected]
  • LayerZero is hovering at $1.79.
  • ZRO trading volume dropped by 28%.

As of March 2nd, the crypto market opened the day, continuing the bearish ride. The Fear and Greed Index value is settled at 15, exhibiting extreme fear. With this momentum, the digital assets are charted in the red, including Bitcoin (BTC) and Ethereum (ETH). In the last 24 hours, among the altcoins, LayerZero (ZRO) has posted a 2.26% loss in value.  

The asset’s lowest trading zone was noted at $1.72, and gradually, it rose toward $1.89, breaking a few key resistances. The CoinMarketCap data has revealed that LayerZero is trading in the $1.79 range at press time. With the market cap at $544.77 million, the daily trading volume has dropped by 28.76%, touching the $105.12 million mark.

The current bullish trajectory of LayerZero might trigger the price to mount higher to the resistance at around $1.83. Assuming the upside momentum builds more power, the golden cross could unfold and likely take the price up above $1.87. On the flip side, if the bears take control, the LayerZero price could fall to the nearest support at $1.75. If the correction on the downside intensifies, it will initiate the formation of a death cross, gradually leading the price below $1.71.

LayerZero Gains Short-Term Strength with Indicators Turning Favourable

The technical indicators of LayerZero reveal that the Moving Average Convergence Divergence line is briefly above the signal line. This hints at a short-term bullish move, and if the MACD moves higher, it may trigger further upside. However, a quick drop weakens the ongoing momentum.

Moreover, ZRO’s Chaikin Money Flow (CMF) indicator is positioned at 0.14, reflecting solid buying pressure, with money steadily flowing into the asset. With accumulation happening, the buyers are showing stronger interest than the sellers. If it rises further, it helps strengthen the bullish trend. 

LayerZero’s daily Relative Strength Index (RSI) at 57.47 indicates a moderate bullish tone in the market. This level is above the neutral mark, with growing buying strength. The asset is far from the overbought zone, and a move below 50 weakens the momentum for a possible consolidation.

Besides, the Bull Bear Power (BBP) value of 0.159 suggests a slight bullish strength. Notably, the price is holding above its average level, showing steady buying strength and improving momentum. It likely supports a constructive short-term outlook when the reading continues to rise.

Top Updated Crypto News

Will AAVE Reset Monthly Momentum or Lose Steam and Remain in the Red?

Source: https://thenewscrypto.com/bulls-vs-bears-battle-over-layerzero-zro-will-it-break-higher-or-pull-back/

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09